BackSinphar Pharmaceutical Ltd. Overview

Sinphar Pharmaceutical Ltd. Receivables

Track Sinphar Pharmaceutical Ltd.'s receivables ($680M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$679.56M
↑ 0.72% YoYΔ $4.86M vs prior year quarter

Peer trimmed avg / median

Loading

Sinphar Pharmaceutical Ltd. Receivables History

Loading

Sinphar Pharmaceutical Ltd. vs. peers: Receivables Comparison

Loading

Sinphar Pharmaceutical Ltd. Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Sinphar Pharmaceutical Ltd. (1734.TW) FAQ

Sinphar Pharmaceutical Ltd. (1734.TW) currently reports a receivables of $680M as of June 2026. That compares with $670M in the prior-year period — up 0.7% year over year. Use the charts on this page to explore Sinphar Pharmaceutical Ltd.'s receivables history and peer comparisons.

Sinphar Pharmaceutical Ltd.'s receivables increased from $670M to $680M — a 0.7% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Sinphar Pharmaceutical Ltd. reported $680M in receivables as of June 2026. That compares with $670M in the prior-year period — up 0.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $680M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Sinphar Pharmaceutical Ltd., and consider following 1734.TW for alerts when major investors trade the stock.